Reporting Error | ClinicLens
In the Original Investigation titled “Hospital Adoption and Pricing for Oncology Biosimilars” published online March 11, 2026, how Medicare marks up acquisition of oncology biosimilars compared with biologics was adjusted in the article’s Discussion section. This was corrected on
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.